✦ LIBER ✦

6513 ORAL A phase II study of erlotinib (E) and bevacizumab (B) in patients (pts) with previously untreated stage IIIB/IV non-small-cell lung cancer (NSCLC)

✍ Scribed by Dingemans, A.; Groen, H.J.M.; Smit, E.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of intravenous adenosine

✍ Charles M. Haskell; Evelyn Mendoza; Katherine M.W. Pisters; Frank V. Fossella; R 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 69 KB

A phase II study of weekly gemcitabine a

✍ Bhatia, Sumeet; Hanna, Nasser; Ansari, Rafat; Pletcher, William; Einhorn, Lawren 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 93 KB

A multicenter, phase II study of combina

✍ Edelman, G; Melville, S; Meyer, W; Napier, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

130 POSTER Phase II trial of Sequenced B

✍ E. Cohen; R. Govindan; M. Kozloff; A. Mauer; P. Hoffman; T. Karrison; J. Stein; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 73 KB

A phase II study with paclitaxel and gem

✍ Ginopoulos, P.; Danikas, D.D.; Asimakopoulos, C.; Mastronikolis, N.S.; Kiriazis, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

14 Phase II study of biweekly vinorelbin

✍ Chen, Chih-Hung; Chang, Wen-Jeng; Tsai, Ying-Hwang; Tsao, Thomas C.Y. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB